BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$18.04
Tradestie Score
63
Market Cap
$212.23M
Revenue Growth
0.9%
Analyst Upside
+174.4%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
COLL Collegium Pharmaceutical, Inc. Common Stock
$34.64
$1.11B 16.9 58 Compare
CRON Cronos Group Inc. Common Share
$2.68
$1.02B - 53 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$19.80
$931.48M - 66 Compare
BCAX Bicara Therapeutics Inc. Common Stock
$21.69
$906.29M - 60 Compare
MBX MBX Biosciences, Inc. Common Stock
$35.51
$800.41M - 57 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.17
$711.32M - 58 Compare
ESPR Esperion Therapeutics, Inc.
$3.15
$584.71M - 63 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$31.59
$543.32M - 54 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$18.24
$463.20M - 50 Compare
ALMS Alumis Inc. Common Stock
$24.15
$422.50M - 61 Compare

Data updated: Jun 15, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry